| Arnold Michael Conforti, MD | |
|
800 1st St Ste 240, Macon, GA 31201-8300 | |
| (478) 633-6900 | |
| (478) 633-4295 |
| Full Name | Arnold Michael Conforti |
|---|---|
| Gender | Male |
| Speciality | Surgical Oncology |
| Experience | 38 Years |
| Location | 800 1st St Ste 240, Macon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215932041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086X0206X | Surgery - Surgical Oncology | 051872 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical Center, Navicent Health (the) | Macon, GA | Hospital |
| Medical Center Of Peach County, Navicent Health | Byron, GA | Hospital |
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Health Services Of Central Georgia | 9638076730 | 205 |
News Archive
"For 15 years, a dedicated group of doctors has been running a health project in central India called Jan Swasthya Sahyog," the Guardian reports, writing, "In a country where many people have no access to health care, their hospital - which relies on grants and donations - serves a population of almost one million people in rural areas of Bilaspur district in Chhattisgarh state."
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Heavy alcohol drinkers attempt to acquire alcohol despite the threat of a negative consequence more so than light drinkers, a study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging has found, and this behavior is associated with unique activation of brain circuitry in heavy drinkers.
In case of emergency, the improvement creates an alert to bring help to the affected user.
Prolucent™ Workforce Management, the leading partner for healthcare providers seeking to optimize deployment of their workforce, today announced the acquisition of intellectual property assets from Symbio Solutions, Inc. The asset acquisition further strengthens Prolucent's best-of-breed workforce management software platform and will help Prolucent deliver even greater value to the more than 1,000 acute-care hospitals and staffing agencies it currently serves.
› Verified 6 days ago
| Entity Name | Health Services Of Central Georgia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184679482 PECOS PAC ID: 9638076730 Enrollment ID: O20031217000270 |
News Archive
"For 15 years, a dedicated group of doctors has been running a health project in central India called Jan Swasthya Sahyog," the Guardian reports, writing, "In a country where many people have no access to health care, their hospital - which relies on grants and donations - serves a population of almost one million people in rural areas of Bilaspur district in Chhattisgarh state."
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Heavy alcohol drinkers attempt to acquire alcohol despite the threat of a negative consequence more so than light drinkers, a study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging has found, and this behavior is associated with unique activation of brain circuitry in heavy drinkers.
In case of emergency, the improvement creates an alert to bring help to the affected user.
Prolucent™ Workforce Management, the leading partner for healthcare providers seeking to optimize deployment of their workforce, today announced the acquisition of intellectual property assets from Symbio Solutions, Inc. The asset acquisition further strengthens Prolucent's best-of-breed workforce management software platform and will help Prolucent deliver even greater value to the more than 1,000 acute-care hospitals and staffing agencies it currently serves.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arnold Michael Conforti, MD 800 First Street, Suite 240, Macon, GA 31201 Ph: (478) 633-6900 | Arnold Michael Conforti, MD 800 1st St Ste 240, Macon, GA 31201-8300 Ph: (478) 633-6900 |
News Archive
"For 15 years, a dedicated group of doctors has been running a health project in central India called Jan Swasthya Sahyog," the Guardian reports, writing, "In a country where many people have no access to health care, their hospital - which relies on grants and donations - serves a population of almost one million people in rural areas of Bilaspur district in Chhattisgarh state."
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Heavy alcohol drinkers attempt to acquire alcohol despite the threat of a negative consequence more so than light drinkers, a study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging has found, and this behavior is associated with unique activation of brain circuitry in heavy drinkers.
In case of emergency, the improvement creates an alert to bring help to the affected user.
Prolucent™ Workforce Management, the leading partner for healthcare providers seeking to optimize deployment of their workforce, today announced the acquisition of intellectual property assets from Symbio Solutions, Inc. The asset acquisition further strengthens Prolucent's best-of-breed workforce management software platform and will help Prolucent deliver even greater value to the more than 1,000 acute-care hospitals and staffing agencies it currently serves.
› Verified 6 days ago
Howard J Perofsky, M D Surgery Medicare: Accepting Medicare Assignments Practice Location: 682 Hemlock St, Suite 230, Macon, GA 31201 Phone: 478-742-4847 Fax: 478-742-5442 | |
Dr. Brown Nnamdi Ekeledo, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 770 Pine St, Suite 550, Macon, GA 31201 Phone: 478-746-2719 Fax: 478-746-4808 | |
Stacey M Lowe, Surgery Medicare: Not Enrolled in Medicare Practice Location: 146 Wesleyan Way, Macon, GA 31210 Phone: 205-712-4245 | |
Dudley Benjamin Christie Iii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 840 Pine St Ste 750, Macon, GA 31201 Phone: 478-633-1458 Fax: 478-633-5025 | |
Heidi Jo Haun, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 777 Hemlock St, Macon, GA 31201 Phone: 478-633-1891 | |
Mr. Taylor Wright Mclendon, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1550 College St, Macon, GA 31207 Phone: 478-808-8517 | |
Dr. Hany N Atalah, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 4801 Oxford Rd, Macon, GA 31210 Phone: 443-799-8823 |